study of paraneoplastic syndrome patterns in patients with bronchogenic carcinoma

Paraneoplastic syndromes, which are the distant effect of underlying carcinoma, which can present early, well before the primary lung lesion produces local symptoms and even when the tumor is undetected or very small. Paraneoplastic syndromes are common in patients with bronchogenic carcinoma. They may be the presenting finding or the first sign of recurrence. To assess the incidence and pattern of paraneoplastic syndrome [PNS] in patients with bronchogenic carcinoma. Peripheral Hospital in Kuwait. Retrospective study. A retrospective study of 52 confirmed bronchogenic carcinoma patients occurring from January 2000 to June 2004 in our hospital was carried out. The Medical records of all the confirmed cases of bronchogenic carcinoma admitted between January 2000 and June 2004 were reviewed. The clinical and biochemical parameters recorded were: age, sex, underlying medical illness, presentation complete blood count, blood urea, electrolytes and serum calcium levels, and appropriate hormone levels where indicated. The localization of the tumors was done by chest x-ray and CT scan. Tissue biopsy was obtained by bronchoscopy or under CT scan guidance and histopathological examination of the specimen was carried out. The type and pattern of PNS if any was noted. These parameters were entered into a database and later analyzed. The data management and statistical package used was Epi Info version 6 provided readily by the CDC [Centre for Disease Control] Bethesda USA. Forty-nine patients were male and 3 were females. All were heavy smokers or exsmokers. The histological types were 12 [22.4%] small cell carcinoma and 40 [67.6%] nonsmall carcinoma. The mean age 67.46 +/- 12.15 years. Associated illness found was diabetes mellitus [DM] ' 24 [46%], hypertension - 33 [63.6%], and chronic obstructive pulmonary disease [COPD] - 14 [27%]. Almost all the patients presented with cough - 52 [100%], shortness of breath [SOB] - 51 [99%], haemoptysis - 22 [42%], pleural pain - 16 [31%] and fever - 22 [42%] and weight loss - 39 [75%]. The PNS found were: Hypercalcemia - 22 [42%], thrombocytosis - 5 [9.6%], limbic encephalitis - 3 [5.8%], SIADH - 3 [5.8%], peripheral neuropathy - 2 [3.8%], GBS - 1 [1.9%], pancytopenia - 3 [5.8%]. There was no case with ACTH secretion or Lambert-Eaton syndrome. Hypercalcemia, thrombocytosis, SIADH, pancytopenia, limbic encephalitis and other unexplained neurological problems occurring in the middle aged or elderly smokers should arouse the suspicion of an occult bronchogenic carcinoma

Carcinoma de pequenas células do esôfago com apresentaçäo múltipla: relato de caso e revisäo da literatura / Multiple small cell carcinoma of the esophagus: report of a case and literature review

Paciente de 47 anos, tabagista e etilista pesado, apresntou quadro de dor abdominal, emagrecimento, febre vespertina e sudorese noturna. A endoscopia digestiva alta mostrou lesäo sugestiva de neoplasia esofagiana avançada, acometendo amplamente o órgäo. A bipsia diagnosticou carcinoma indiferenciado de pequenas células. O paciente foi submetido a quimioterapia, porém veio a falecer quatro meses após o diagnóstico. O presente caso é particularmente interessante por sua apresentaçäo múltipla no esôfago e sua raridade

Lectin histochemistry of normal lung and pulmonary carcinoma.

Normal bronchopulmonary tissues and pulmonary carcinomas including three major types (squamous cell carcinoma, adenocarcinoma, and small-cell carcinoma) were studied using three biotinylated lectins (Bauhinia purpurea [BPA], Phaseolus vulgaris [PHA], and Maclura pomifera [MPA]) by avidin biotin peroxidase complex (ABC) method. The study demonstrated that BPA binds with macrophages and pneumocytes of normal tissue, and with adenocarcinoma and small-cell carcinoma, but nonreactive with squamous cell carcinoma. PHA and MPA bound to all the normal components of bronchopulmonary tree and carcinomas of all types. Adenocarcinoma showed the highest density of reacting sites for BPA and MPA, and squamous cell carcinoma showed the highest binding sites for PHA, while small-cell carcinoma were the lowest reacting variant for all lectins. Lectins used in this study have limited usefulness for the diagnosis of pulmonary neoplasms.